🇺🇸 FDA

Company profile · Sponsor

Sana

Sana Biotechnology

SANA · NYSE biotech SEATTLE, WA, USA
Pipeline
19
Drugs
2
Patents
8

Quick answer

Sana (SANA) is a biotech company. headquartered in SEATTLE, WA, USA. listed on NYSE. NovaPharmaNews links 19 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker SANA
Exchange NYSE
Company type biotech
Headquarters SEATTLE, WA, USA
SEC CIK 0001770121

Pipeline (19)

Search pipeline →

  1. Sodio ioduro (I131) Curium Netherlands 37-7400 MBq capsula rigida, TAPAZOLE 5 mg compresse

    Sana

    Graves' disease and Graves' orbitophaty

    phase 3 small molecule active

    1 trial

  2. AZITROMICINA ZENTIVA 500 mg compresse rivestite con film, Bassado 100 mg compresse, CEBION

    Sana

    Breast Cancer

    phase 2 small molecule active

    1 trial

  3. Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione, DOXORUBICINA ACCORD HEALTHCARE ITALIA 2 mg/ml concentrato per soluzione per infusione

    Sana

    Pleural carcinosis

    phase 2 small molecule active

    1 trial

  4. DEFLAN 22,75 mg/ml gocce orali, sospensione

    Sana

    Laminopathies

    phase 2 small molecule active

    1 trial

  5. Dexmedetomidine injection

    Sana

    Post Spinal Shivering

    phase 2 small molecule active

    1 trial

  6. HCQ01

    Sana

    2019 Novel Coronavirus

    phase 2 small molecule active

    2 trials

  7. Hydroxyurea

    Sana

    Thalassemia, Beta

    phase 2 small molecule active

    1 trial

  8. Myocet (Non-pegylated liposomal doxorubicin (NPLD))

    Sana

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  9. SUL-238, Identical to test product except without active substance

    Sana

    Parkinson’s Disease

    phase 2 small molecule active

    1 trial

  10. TREDIMIN 25.000 U.I. /2,5 ml soluzione orale

    Sana

    haematologic condition who need staminal cells transplant

    phase 2 small molecule active

    1 trial

  11. Methotrexate

    Sana

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial

  12. SC262

    Sana

    Non Hodgkin's Lymphoma

    phase 1 small molecule active

    1 trial

  13. SC291

    Sana

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  14. SC291

    Sana

    Lupus Erythematosus

    phase 1 mab active

    1 trial

  15. UP421

    Sana

    Type1diabetes

    phase 1 mab active

    1 trial

  16. Liraglutide

    Sana

    Morbid Obesity

    approved small molecule completed

    1 trial

  17. Prednisone Mylan Pharma 5 mg compresse, Prednisone Mylan Pharma 5 mg compresse

    Sana

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  18. Sana Device (Control)

    Sana

    Fibromyalgia

    small molecule terminated

    1 trial

  19. dexmedetomidine

    Sana

    Laparoscopic Cholecystectomy

    small molecule active

    1 trial

Drugs (2)

Search drugs →

  1. cycloserine

    SEROMYCIN

    ORAL approved

  2. dolutegravir

    DOVATO

    ORAL approved

    J05AR

Patents (8)

Search patents →

  1. US 12427199

    Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12409213

    Live attenuated oral vaccine against shigellosis and typhoid fever

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12246059

    Stable hybrid FC fusion G-CSF formulation

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12171822

    Infectious plasmodium sporozoites grown in vitro

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12156870

    Antibody drug conjugates comprising sting agonists

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12129288

    Polynucleotides heterodimers of soluble interferon receptors and uses thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12077543

    P2X3 and/or P2X2/3 compounds and methods

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11987628

    Methods and compositions for modulating CAR-T activity

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Sana?

Sana (SANA) is a biotech company. headquartered in SEATTLE, WA, USA. listed on NYSE. NovaPharmaNews links 19 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does Sana sponsor?

We track 19 ClinicalTrials.gov-linked programs for Sana, including Sodio ioduro (I131) Curium Netherlands 37-7400 MBq capsula rigida, TAPAZOLE 5 mg compresse and 18 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sana company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.